The ability to trigger drug release from a device (i.e. on-demand drug delivery) can enable control over the exact timing (onset and offset) and magnitude of therapeutic effect, and also provide spatiotemporal control which can enhance the therapeutic index. We have developed nano-, micro-, and macroscopic triggerable drug delivery systems that respond to external energy sources including light, ultrasound, and magnetism. Read More …

We are interested in methods for getting drugs into the middle ear by non-invasive means using a range of drug delivery technologies. Read More …

We are looking at light as a trigger and targeting for drug delivery systems, as well as for surface reactions. Read More …

We have an active interest in the use of inorganic nanomaterials for a range of applications including triggerable nanomaterials and surfaces, bio-applications of nanoelectronics, and tissue-engineered nanocomposites. Read More …

We are studying a range of topics including nanoparticulate drug delivery systems, nanostructured engineered tissues, and nanoscale sensors. These are further applied in triggered and/or targeted systems, as well as tissue engineering applications. Our interests extend to the use of inorganic nanomaterials. Read More …

This is the longest-running area of research in our laboratory. We have designed and developed a range of formulations to produce prolonged nerve blockade, including drugs in free solution, or associated with chemical permeation enhancers, micro-and nanoparticles, hydrogels, and others drug delivery systems. We have a particular interest in means of preventing or at least mitigating the development of neuropathic pain. Read More …